Core Viewpoint - The A-share market showed positive momentum with the ChiNext Index rising by 0.99%, driven by strong performance in the solid-state battery sector and other key industries [1] Market Performance - The Shanghai Composite Index increased by 0.38% - The Shenzhen Component Index rose by 0.53% - The ChiNext Index experienced a gain of 0.99% [1] Sector Highlights - The solid-state battery concept was notably active, with leading companies such as Lingpai Technology and Guoxuan High-Tech hitting the daily limit of 20% increase - Other sectors that performed well included coal, precious metals, chemical pharmaceuticals, electricity, insurance, innovative drugs, and CRO concepts [1] Underperforming Sectors - Sectors that saw declines included electric machinery, real estate services, shipbuilding, consumer electronics, controllable nuclear fusion, and PEEK materials [1] Overall Market Sentiment - More than 1,600 stocks in the market experienced an increase, indicating a broadly positive sentiment among investors [1]

这几只票暗盘资金正在偷偷流入，立即查看>> CRO概念板块短线拉升，河化股份（000953）涨停，金凯生科（301509）、睿智医药（300149）、诺 思格（301333）、昊帆生物（301393）、义翘神州（301047）等纷纷走高。 ...

板块涨幅居前的十大牛股分别是：阳光诺和（5.1%）、毕得医药（1.52%）、昭衍新药（0.88%）、药 康生物（0.85%）、诺泰生物（0.79%）、泓博医药（0.77%）、百诚医药（0.61%）、联化科技 （0.47%）、昊帆生物（0.45%）、泰格医药（0.4%）、美迪西（0.3%）、金凯生科（0.06%）、皓元医 药（0.05%）、迦南科技（0.0%）、睿智医药（0.0%）、太龙药业（-0.18%）、成都先导（-0.2%）、 义翘神州（-0.23%）、百花医药（-0.28%）、凯莱英（-0.33%） 本文源自：金融界 序代码股票名称现价涨跌幅主力资金净额主力资金净占比1300630普利退0.82-8.89-415.18 万-16.232301520万邦医药38.8-2.56-119.21万-1.503300759康龙化成22.41-2.52-2033.75万-4.674603739蔚 蓝生物13.6-1.73-655.01万-4.535603229奥翔药业8.13-1.69-488.23万-7.946000739普洛药业13.81- 1.642593.46万12.907688238和元生物5.71-1. ...

| 代码 名称 | 现价 | 涨跌 涨幅↓ | | --- | --- | --- | | 300255 常山药业 | 13.78 | +2.30 +20.03% | | 300363 博腾股份 | 29.64 | +4.18 +16.42% | | 002038 双鹭药业 | 11.74 | +1.07 +10.03% | | 000813 德展健康 | 4.54 | +0.41 +9.93% | | 688166 博瑞医药 | 29.39 | +2.29 +8.45% | | 688076 诺泰牛物 | 39.66 | +2.97 +8.09% | | 301393 吴帆生物 | 78.79 | +4.59 +6.19% | | 600721 百花医药 | 8.47 | +0.47 +5.88% | | 605116 奥锐特 | 23.01 | +1.20 +5.50% | | 301092 争光股份 | 32.62 | +1.24 =+1.95% | 自9月8日以来，医药各细分板块进入稳步上行阶段，其中涨幅最大的减肥药板块，14个交易日内涨超 22%。 今日，医药板块情绪格外高涨。 A股方面，CRO概念 ...

截至4月24日收盘，CRO概念上涨0.96%，位居概念板块涨幅第9，板块内，38股上涨，金凯生科20%涨 停，双成药业、河化股份、凯莱英等涨停，峆一药业、博腾股份、昊帆生物等涨幅居前，分别上涨 6.50%、5.35%、4.50%。跌幅居前的有星昊医药、康鹏科技、蔚蓝生物等，分别下跌8.43%、4.30%、 3.46%。 今日涨跌幅居前的概念板块 | 业 | | --- | | 603259 | 药明康 | 0.36 | 1.49 | 2800.31 | 1.32 | | --- | --- | --- | --- | --- | --- | | | 德 | | | | | | 300363 | 博腾股 | 5.35 | 5.1 1 | 2230.39 | 5.99 | | | 份 | | | | | | 300725 | 药石科 | 0.38 | 4.14 | 1420.31 | 6.43 | | | 技 | | | | | | 300347 | 泰格医 | 0.35 | 1.99 | 1315.18 | 2.54 | | | 药 | | | | | | | 圣诺生 | | | | | | 688117 | ...

Market Overview - Major indices opened lower but the Shanghai Composite Index rebounded, with sectors such as beauty care and public utilities rising over 1% [1] - The PEEK materials concept surged, with stocks like Zhongxin Fluorine Materials hitting the daily limit and Xinhan New Materials rising over 10% [1] - The CRO concept showed strong performance, with Jinkai Biotechnology hitting the daily limit and companies like Kailai Ying and Lingkang Pharmaceutical also reaching the limit. Jinkai Biotechnology reported a 41.83% increase in revenue and a 183.24% increase in net profit for Q1 [1] New Listings - Two new stocks were listed today: N Jiangshunke and N Tianyou. N Jiangshunke opened at 84.5 CNY per share, focusing on aluminum profile extrusion molds and related products [4] - N Tianyou opened at 140 CNY per share, specializing in the research, design, production, and sales of automotive instruments, with plans to expand into smart cockpit areas [6] Financing Activities - As of April 23, the total market financing balance reached 1.8 trillion CNY, an increase of 20.26 billion CNY from the previous trading day [6] - On April 23, 39 stocks had net financing purchases exceeding 50 million CNY, with BYD leading at 302 million CNY, followed by Zijin Mining and Shijia Photon [7][8] Shareholder Reduction Plans - On April 24, 20 companies announced shareholder reduction plans, marking a significant day for such announcements in April. Companies with the highest proposed reduction ratios included Yinglian Co., Duopule, and Fenglong Co. [9] Upcoming Dividends - Eight companies are entering the dividend implementation season, with five companies offering cash dividends of 1 CNY or more per 10 shares. Longxun Co. is the most generous, offering 7 CNY per 10 shares [10][11]

暗盘资金正涌入这些股票，点击速看>>> CRO概念股盘初拉升，金凯生科（301509）20cm涨停，双成药业（002693）逼近涨停，昊帆生物 （301393）、凯莱英（002821）、泓博医药（301230）上扬。 ...

CRO概念股盘初下挫，双成药业（002693）跌停，万邦医药（301520）跌超5%，谱尼测试 （300887）、新天地（301277）、金凯生科（301509）跟跌。 ...

A股CRO概念震荡反弹，双成药业6天5板，诺思格涨超10%，河化股份、新天地、宣泰医药、昭衍新药 等跟涨。 ...

Group 1 - The CRO (Contract Research Organization) sector experienced a significant downturn, with WuXi AppTec hitting the daily limit down [1] - Other companies in the sector, such as Kelun Pharmaceutical, also approached the daily limit down, indicating a widespread decline [1] - Additional firms like Boteng, Meinohua, Zhaoyan New Drug, Jiuzhou Pharmaceutical, and Baihua Medicine followed suit with declines [1]